1. a) Is an authorized user who meets the requirements of Section 335.9100 or equivalent U.S. Nuclear Regulatory Commission or Agreement State requirements; or

2. b) Has:

   1. 1) Completed 24 hours of classroom and laboratory training applicable to the medical use of strontium-90 for ophthalmic radiation therapy. The training shall include:

      1. A) Radiation physics and instrumentation;
      2. B) Radiation protection;
      3. C) Mathematics pertaining to the use and measurement of radioactivity;
      4. D) Radiation biology; and

   2. 2) Completed clinical training in ophthalmic radiation therapy under the supervision of an authorized user at a medical institution, clinic, or private practice that includes the use of strontium-90 for the ophthalmic treatment of 5 individuals. The supervised clinical training shall include:

      1. A) Examination of each individual to be treated;
      2. B) Calculation of the dose to be administered;
      3. C) Administration of the dose; and
      4. D) Follow-up and review of each individual's case history; and
   3. 3) Obtained written attestation that the individual has satisfactorily completed the requirements in subsections (b)(1) and (b)(2) and is able to independently fulfill the radiation safety-related duties as an authorized user of strontium-90 for ophthalmic use. The attestation shall be signed by a preceptor authorized user who meets the requirements in this Section, Section 335.9100, 335.9160, or equivalent U.S. Nuclear Regulatory Commission or Agreement State requirements.

Except as provided in Section 335.9160, the licensee shall require the authorized user using only strontium-90 for ophthalmic radiation therapy to be a physician who:

(Source: Amended at 46 Ill. Reg. 966, effective December 21, 2021)